Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
PE-Backed Elevate ENT Partners Acquires Texas Practice
Elevate ENT Partners, backed by Boston-based private equity firm Audax Private Equity, announced on March 14 that it acquired Ear, Nose & Throat Associates of Texas(ENTtex). This marks Elevate ENT Partners’ first transaction in 2023 and expands the company’s foothold in Texas. The financial terms of the acquisition were not disclosed. Located in Frisco, McKinney, Plano, Anna and Prosper, Texas, ENTtex is run by six providers. The practice was founded in 2004. Elevate ENT Partners invests in private ear, nose & throat (ENT) and allergy practices across the U.S. and provides scalable infrastructure to help practices reach the next level in terms of financial management,... Read More »
MariMed Completes Acquisition of Medical Cannabis Operator Ermont
MariMed, Inc announced that it has acquired the operating assets of Ermont Inc., a vertically integrated medical cannabis operator located in Quincy, Massachusetts. The closing of this transaction is the result of a successful restructuring conducted by Ermont’s court-appointed receiver Opus Consulting Partners LLC. Opus Consulting and MariMed negotiated this transaction with court approval. The acquisition marks the second medical dispensary for MariMed in Massachusetts, completing MariMed’s buildout to the maximum allowable by state regulations. The transaction closed on March 9, 2023, and the dispensary began operations under the Panacea Wellness brand name the following day. This... Read More »
Allied OMS Acquires Practices in Oregon and Colorado
Allied OMS, a portfolio company of Chicago-based private equity firm DuneGlass Capital, announced on March 13 that it acquired three dental practices, marking the company’s first acquisitions of the year. Advanced Oral and Maxillofacial Surgery is run by Dr. James Lessig and Dr. Thomas S. Michalik. It has locations in Englewood and Littleton, Colorado. Their expertise includes corrective jaw surgery and wisdom tooth removal. With locations in Eugene, Roseburg and Florence, Oregon, Oregon Oral Surgeons is run by four physicians. A provider of oral and maxillofacial surgical care, Oregon Oral Surgeons is one of the few practices in the country that places its dental implants using CT-guided... Read More »
Parkview Physicians Group Acquires Fairhaven Obstetrics and Gynecology
Parkview Physicians Group announced on March 8 that it acquired Fairhaven Obstetrics and Gynecology, a three-physician OB/GYN practice in Goshen, Indiana. This acquisition expands Parkview Physicians Group’s presence in Indiana. The financial terms of the transaction were not disclosed. Parkview Physicians Group is one of the largest not-for-profit healthcare providers in northeast Indiana. It operates more than 10 locations across the state. According to data captured in the LevinPro HC database, this acquisition marks the 104th Physician Medical Groups transaction and the fifth OB/GYN acquisition of the year. From January 1, 2022, through March 8, 2022, there were nine OB/GYN... Read More »
McLeod Physician Associates Acquires Florence Neurosurgery and Spine Center
McLeod Physician Associates announced that it acquired Florence Neurosurgery and Spine Center for an undisclosed price. Operating out of two locations in Florence, South Carolina, Florence Neurosurgery and Spine Center is run by eight providers and a support team of five employees. McLeod Physician Associates’ network comprises seven hospitals with locations in Florence, Darlington, Dillon, Manning, Cheraw, Loris and Little River, South Carolina. It provides an array of specialized services in heart and vascular treatment, cancer, surgery, orthopedics as well as women’s and children’s health. According to data captured in the LevinPro HC database, this acquisition marks the 103rd Physician... Read More »
Thermo Fisher Scientific: Leading the Diagnostic M&A Market With An Aggressive Acquisition Strategy
With 68 diagnostic M&A deals reported throughout 2022, many predicted the demand for the specialty would slow and, possibly, return to its pre-COVID-19 deal volume. Yet, the first few months of 2023 are showing higher than pre-COVID deal numbers. According to data captured in the LevinPro HC database, with 14 acquisitions the diagnostic market accounts for 56% of the 2023 Laboratories, MRI and Dialysis M&A market. In the same time frame of 2022, 25 diagnostic acquisitions were reported, accounting for more than 84%. The most active type of buyer is other laboratories, representing 43% of the diagnostic buyers. And most of the acquirers are public companies, also totaling... Read More »
Pfizer Acquires Seagen for $43 Billion
Pfizer Inc. has acquired Seagen Inc. for $43 billion, representing the largest purchase price for a biotechnology deal in 2023. The transaction is expected to be completed in late 2023 or early 2024. Pfizer will pay $229 in cash for each share of Seagen and pay primarily through $31 billion in new, long-term debt. Shares of Pfizer rose 2% to $40.26 after markets opened on March 13 while Seagen’s stock soared more than 15% to nearly $200. Seagen Inc. specializes in working with antibody-drug conjugate technology. Its key products use lab-made proteins called monoclonal antibodies that seek out cancer cells to help deliver a cancer-killing drug while sparing surrounding tissue. It also has a... Read More »
Sanofi Acquires Provention Bio for $2.9 Billion
Sanofi S.A. announced on March 13 that it acquired Lebanon, New Jersey-based Provention Bio. The purchase price was $25 per share in cash, representing an equity value of approximately $2.9 billion. The transaction adds a first-in-class therapy in type 1 diabetes to Sanofi’s core asset portfolio in general medicines and further drives its strategic shift toward products with a differentiated profile. Provention Bio is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening, immune-mediated diseases. Provention ended Q3:22 with $186.5 million in cash, cash equivalents and marketable... Read More »
Woodside Health Expands Atlanta MSA MOB Footprint
Woodside Health has acquired Research Court, an 80,000-square-foot medical office building (MOB) in Suwanee, Georgia. This marks Woodside Health’s third acquisition in the Atlanta MSA and the 49th addition to its portfolio. Crossgate Partners sold the asset for an undisclosed price. Research Court encompasses two one-story buildings built in 2001 on a 6.4-acre site. The asset was 88% occupied at the time of the sale with its roster featuring medical and office tenants. The property is 30 miles from downtown Atlanta and has access to State Route 141. The property previously traded in 2020 when Crossgate bought it from Alta Properties for $10 million, financing the purchase with a $6.6... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
